Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2013 (2013), Article ID 235190, 6 pages
http://dx.doi.org/10.1155/2013/235190
Clinical Study

Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria

1Department of Internal Medicine, University of Calabar Teaching Hospital, PMB 1278, Cross River State, Nigeria
2Department of Medicine, Aminu Kano Teaching Hospital, PMB 3452, Kano, Nigeria
3Department of Community Medicine, University of Calabar Teaching Hospital, PMB 1278, Cross River State, Nigeria
4Zankli Medical Centre, Plot 1021 Shehu YarAdua Way, Abuja, Nigeria

Received 21 February 2013; Revised 24 June 2013; Accepted 18 July 2013

Academic Editor: S. L. Johnston

Copyright © 2013 Akaninyene Otu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Tuberculosis Control: WHO Report 2010, WHO, Geneva, Switzerland.
  2. I. J. Eltringham and F. Drobniewski, “Multiple drug resistant tuberculosis: aetiology, diagnosis and outcome,” British Medical Bulletin, vol. 54, no. 3, pp. 569–578, 1998. View at Google Scholar · View at Scopus
  3. M. C. Becerra, I. F. Pachao-Torreblanca, J. Bayona et al., “Expanding tuberculosis case detection by screening household contacts,” Public Health Reports, vol. 120, no. 3, pp. 271–277, 2005. View at Google Scholar · View at Scopus
  4. World Health Organization, Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs, WHO, Geneva, Switzerland, 2004.
  5. K. R. Rijal, P. Ghimire, D. Rijal, and D. S. Bam, “The pattern of anti-tuberculosis drug resistance in pulmonary tuberculosis patients,” Journal of Institute of Medicine, vol. 27, pp. 26–28, 2005. View at Google Scholar
  6. World Health Organization, MultiDrug and Extensively Drug Resistant TB (M/XDR-TB) 2010 Global Report on Surveillance and Response 2010 WHO/HTM/TB/2010, WHO, Geneva, Switzerland, 2010.
  7. D. A. Mitchison, “The Garrod Lecture. Understanding the chemotherapy of tuberculosis—current problems,” Journal of Antimicrobial Chemotherapy, vol. 29, no. 5, pp. 477–493, 1992. View at Google Scholar · View at Scopus
  8. L. P. Ormerod, “Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society,” Thorax, vol. 45, no. 5, pp. 403–408, 1990. View at Google Scholar · View at Scopus
  9. R. Johnson, E. M. Streicher, G. E. Louw, R. M. Warren, P. D. van Helden, and T. C. Victor, “Drug resistance in Mycobacterium tuberculosis,” Current Issues in Molecular Biology, vol. 8, no. 2, pp. 97–112, 2006. View at Google Scholar · View at Scopus
  10. World Health Organization, Global Tuberculosis Control: WHO Report 2011, WHO, Geneva, Switzerland, 2011.
  11. I. W. Fawcett and B. J. Watkins, “Initial resistance of Mycobacterium tuberculosis in Northern Nigeria,” Tubercle, vol. 57, no. 1, pp. 71–73, 1976. View at Google Scholar · View at Scopus
  12. A. O. Kehinde, F. A. Obaseki, O. C. Ishola, and K. D. Ibrahim, “Multidrug resistance to Mycobacterium tuberculosis in a tertiary hospital,” Journal of the National Medical Association, vol. 99, no. 10, pp. 1185–1189, 2007. View at Google Scholar · View at Scopus
  13. L. Lawson, M. A. Yassin, S. T. Abdurrahman et al., “Resistance to first-line tuberculosis drugs in three cities of Nigeria,” Tropical Medicine and International Health, vol. 16, no. 8, pp. 974–980, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Idigbe, T. Sofola, R. Akinosho, and D. Onwujekwe, “Initial drug resistance among HIV seropositive prison inmates in Lagos, Nigeria,” in International Conference on AIDS, vol. 12, p. 137, 1998.
  15. Federal Republic of Nigeria, “Provisional results of the main findings of 2006 census,” Official Gazette, vol. 94, no. 4, 2007, Government notice No. 3. B 52. Lagos. Federal Republic of Nigeria. View at Google Scholar
  16. World Health Organization, Framework for Effective Tuberculosis Control. World Health Organization Document 1994, WHO/TB/94.179:1-7.
  17. World Health Organization, International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association, “Revised international definitions in tuberculosis control,” International Journal of Tuberculosis and Lung Disease, vol. 5, no. 3, pp. 213–215, 2001. View at Google Scholar · View at Scopus
  18. L. Lawson, A. G. Habib, M. I. Okobi et al., “Pilot study on multidrug resistant tuberculosis in Nigeria,” Annals of African Medicine, vol. 9, no. 3, pp. 184–187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. K. Sharma and A. Mohan, “Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control,” Chest, vol. 130, no. 1, pp. 261–272, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Mukherjee, M. L. Rich, A. R. Socci et al., “Programmes and principles for management of multidrug resistant tuberculosis,” The Lancet, vol. 372, no. 9407, pp. 474–481, 2004. View at Google Scholar
  21. A. Pablos-Méndez, C. A. Knirsch, R. G. Barr, B. H. Lerner, and T. R. Frieden, “Nonadherence in tuberculosis treatment: predictors and consequences in New York City,” American Journal of Medicine, vol. 102, no. 2, pp. 164–170, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. E. O. Idigbe, J. P. Duque, E. K. O. John, and O. Annam, “Resistance to antituberculosis drugs in treated patients in Lagos, Nigeria,” Journal of Tropical Medicine and Hygiene, vol. 95, no. 3, pp. 186–191, 1992. View at Google Scholar · View at Scopus
  23. A. E. Ani, J. Idoko, Y. B. Dalyop, and S. L. Pitmang, “Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 103, no. 1, pp. 67–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Desta, D. Asrat, E. Lemma, M. Gebeyehu, and B. Feleke, “Prevalence of smear negative pulmonary tuberculosis among patients visiting St. Peter's tuberculosis Specialized Hospital, Addis Ababa, Ethiopia,” Ethiopian Medical Journal, vol. 47, no. 1, pp. 17–24, 2009. View at Google Scholar · View at Scopus
  25. D. Asmamaw, B. Seyoum, E. Makonnen et al., “Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia,” Ethiopian Medical Journal, vol. 46, no. 4, pp. 367–374, 2008. View at Google Scholar
  26. M. J. Kabedi, M. Kashongwe, J. M. Kayembe et al., “Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC),” Bulletin de la Societe de Pathologie Exotique, vol. 100, no. 4, pp. 275–276, 2007. View at Google Scholar · View at Scopus
  27. Y. Yang, X. Li, F. Zhou, Q. Jin, and L. Gao, “Prevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysis,” PLoS ONE, vol. 6, no. 6, Article ID e20343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Sar, C. Keo, C. Leng et al., “Anti-tuberculosis drug resistance and hiv co-infection in phnom penh, cambodia,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 40, no. 1, pp. 104–107, 2009. View at Google Scholar · View at Scopus
  29. T. Dam, M. Isa, and M. Bose, “Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates—a retrospective study from a chest-disease institute in India,” Journal of Medical Microbiology, vol. 54, no. 3, pp. 269–271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. World Health Organization, Global Tuberculosis Control: Epidemiology, Strategy and Financing, WHO, Geneva, Switzerland, 2009.
  31. C. Dye, B. G. Williams, M. A. Espinal, and M. C. Raviglione, “Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis,” Science, vol. 295, no. 5562, pp. 2042–2046, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. K. B. Patel, R. Belmonte, and H. M. Crowe, “Drug malabsorption and resistant tuberculosis in HIV-infected patients,” The New England Journal of Medicine, vol. 332, no. 5, pp. 336–337, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Pereira, S. Tripathy, V. Inamdar et al., “Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India,” Indian Journal of Medical Research, vol. 121, no. 4, pp. 235–239, 2005. View at Google Scholar · View at Scopus
  34. D. Anastasis, G. Pillai, V. Rambiritch, and S. S. Abdool Karim, “A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa,” International Journal of Tuberculosis and Lung Disease, vol. 1, no. 3, pp. 220–224, 1997. View at Google Scholar · View at Scopus
  35. F. A. Post and R. Wood, “HIV infection is not associated with an increased rate of drug-resistant tuberculosis,” South African Medical Journal, vol. 87, no. 7, p. 903, 1997. View at Google Scholar · View at Scopus
  36. J. Murray, P. Sonnenberg, S. Shearer, and P. Godfrey-Faussett, “Drug-resistant pulmonary tuberculosis in a cohort of Southern African goldminers with a high prevalence of HIV infection,” South African Medical Journal, vol. 90, no. 4, pp. 381–386, 2000. View at Google Scholar · View at Scopus